Education and Training​

• FRACP (Medical Oncology, Royal Australasian College of Physicians) ​
• PhD (University of Sydney) ​
• MBBS (University of New South Wales) ​
• BSc(Med)Hons (University of New South Wales)​

Awards​

• NMRC Transition Award (2025) ​
• NMRC CS-IRG New Investigator Grant (NIG; 2022 & 2023) ​
• IASLC Fellowship (2018-2020)​

Research Trials​

• ATORG-003: A single-arm, open-label, phase 2 study of dacomitinib with or without dose titration for the first-line treatment of locally advanced or metastatic non-small cell lung cancer in subjects with an epidermal growth factor receptor (EGFR) activation mutation​